Raising the Bar: How AI-Powered Insights Keep Oncology Trials on Track
In this webinar, “Every Dose Matters — Ensuring the Right Dose, at the Right Time, In Oncology Trials,” Amanda Paley, explores how patients and caregivers can best manage the unique challenges of oncology trials, including multi-drug dosing regimens, from home.
The oncology drug pipeline has grown by 63% since 2013, but the average success rate of oncology drugs is only 3.4%. To address this discrepancy AiCure aims to improve patient support and trial retention, while also providing sponsors and sites with greater visibility into patient behavior, by offering:
- Remote Monitoring: Oncology sites can remotely monitor patients and use real-time communication tools to guide them through complex treatment protocols.
- Actionable Insights: AI-powered insights into trial and site performance empower sponsors to make proactive, data-driven decisions.
- Remote Assessments: Patients can leverage electronic patient-reported outcome (ePRO) assessments and measurements of relevant digital biomarkers (DBM).
“With oncology’s data landscape growing in complexity, we need to arm our sponsors with the tools to drive informed decisions that will improve study outcomes.By partnering with AiCure and leveraging their unique AI-powered insights, our sponsors will gain a deeper understanding of patient behavior through high-quality data capture and develop comprehensive views of the impact of study drug administration and compliance on other data points.”– Krystyna Kowalczyk, President and CEO of Oncobay Clinical
AiCure and OncoBay are partnering to expand access to AI, empowering oncology sponsors with actionable insights to optimize drug development and help improve patients’ quality of life.
Click here to learn more.